Abstract:While most lung cancers are associated with tobacco smoking, prior studies have indicated that 15-20% of cases are found in never smokers. Lung cancer in never smokers (LCINS) shows demographic variations, being more common in females and Asian populations. Epidemiological studies have also identified environmental risk factors for LCINS, including exposure to secondhand tobacco smoke and air pollution. As part of the Sherlock-Lung project (current data freeze of 1217 samples), we generated deep WGS data from a large international cohort of 871 treatment-naïve LCINS recruited from 28 locations across four continents. Our cohort allowed mapping the genomic landscape operative in lung cancer histologies commonly found in never smokers, including adenocarcinomas (n=737) and carcinoids (n=61), as well as other histologies rarely attributed to never smokers (n=73). Information on passive smoking was collected for 458 patients, with 250 being exposed to secondhand smoke. We identified driver alterations and performed mutational signature analyses for single base substitutions (SBS), indels, doublet base substitutions (DBS), copy number alterations, and structural variants. We detected eighteen SBS signatures, with eight not previously linked to LCINS, including SBS4, associated with smoking but also observed in lifelong non-smokers exposed to different environmental mutagens, such as indoor pollution. Several additional signatures were detected in other variant types, including a novel indel signature. Notably, secondhand smoke exposure corresponded to increased SBS burden, although it was not associated with specific signatures. In contrast, we observed a signature-specific association of air pollution (measured as PM2.5 exposure) with SBS, indel, and DBS burden. SBS4 and correlated signatures ID3 and DBS2 were positively associated with PM2.5 exposure. Similarly, clock-like signature SBS5 was highly correlated with PM2.5, potentially acting as a readout of a promotion mechanism where lung cells undergo more cell divisions in individuals living in highly polluted areas. We also observed variability across histologies and ancestries for signatures and driver mutations, including enrichment of signatures SBS17b and SBS40a as well as KRAS mutations in adenocarcinomas from Europeans; aristolochic-acid associated signature SBS22a, and EGFR and TP53 mutations in adenocarcinomas from East Asians; and signature SBS8 and ARID1A mutations in carcinoids from Europeans. The unprecedented size of our cohort allowed us to refine the prevalence and intensity of the driver mutations and mutational signatures involved in LCINS, as well as their variability across ancestries, geographical locations, and histologies. Our results indicate that air pollution may act as both initiator and promoter of neoplastic expansion of LCINS. Citation Format: Marcos Diaz-Gay, Tongwu Zhang, Azhar Khandekar, Burçak Otlu, Shuvro Nandi, Christopher D. Steele, Nathaniel Rothman, Stephen J. Chanock, Qing Lan, Ludmil B. Alexandrov, Maria Teresa Landi. The mutagenic forces shaping the genomic landscape of lung cancer in never smokers [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 2 (Late-Breaking, Clinical Trial, and Invited s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(7_Suppl) nr LB231.

A nested case‐control study of untargeted plasma metabolomics and lung cancer among never‐smoking women within the prospective Shanghai Women's Health Study

Abstract 4974: Prospective study of untargeted urinary metabolomics and risk of lung cancer among female never-smokers in Shanghai, China

Association of Untargeted Urinary Metabolomics and Lung Cancer Risk among Never-Smoking Women in China

Abstract LB136: Global metabolomics identified promising biomarkers for lung cancer risk among former smokers

Epigenome-wide association study of lung cancer among never smokers in two prospective cohorts in Shanghai, China

Abstract 3483: Epigenome-wide association study of lung cancer among never-smokers in two prospective cohorts in Shanghai

Urinary Metabolites of a Polycyclic Aromatic Hydrocarbon and Volatile Organic Compounds in Relation to Lung Cancer Development in Lifelong Never Smokers in the Shanghai Cohort Study

Serum Metabolomics Profiling Reveals Metabolic Alterations Prior to a Diagnosis with Non-Small Cell Lung Cancer among Chinese Community Residents: A Prospective Nested Case-Control Study

A Prospective Study of Immune and Inflammation Markers and Risk of Lung Cancer among Female Never Smokers in Shanghai.

Prediagnostic plasma metabolite concentrations and liver cancer risk: a population-based study of Chinese men

Endogenous sex hormones, aromatase activity and lung cancer risk in postmenopausal never-smoking women

Menstrual and Reproductive Factors in Association with Lung Cancer in Female Lifetime Nonsmokers

Metabolic linkages between zinc exposure and lung cancer risk: A nested case-control study

[Exploratory Research on Developing Lung Cancer Risk Prediction Model in Female Non-Smokers].

Metabolic Obesity Phenotypes and Risk of Lung Cancer: A Prospective Cohort Study of 450,482 UK Biobank Participants

Associations between Longer Leukocyte Telomere Length and Increased Lung Cancer Risk among Never Smokers in Urban China

Prospective Metabolomics Study Identifies Potential Novel Blood Metabolites Associated with Pancreatic Cancer Risk

The role of metabolic perturbations in mediating the effects of ambient air pollution on lung cancer in the cancer prevention studies.

Abstract LB231: The mutagenic forces shaping the genomic landscape of lung cancer in never smokers

Variation in Oral Microbiome is Associated with Future Risk of Lung Cancer among Never-Smokers

A Prospective Investigation of Circulating Metabolome Identifies Potential Biomarkers for Gastric Cancer Risk